GeneDx Holdings Corp
WGS136.910USD
+5.410+4.11%
收盘 10/31, 16:00（美东）报价延迟15分钟
3.96B总市值
1898.84市盈率 TTM
关于 GeneDx Holdings Corp 公司
GeneDx Holdings Corp. 是一家基因组学公司。该公司专注于提供个性化和可操作的健康见解，以指导诊断、指导治疗和改善药物发现。该公司的部门包括 GeneDx，包括 Legacy GeneDx 和 Legacy Sema4。GeneDx 部门主要提供儿科和罕见疾病诊断，重点是全外显子组和基因组测序，以及在较小程度上提供数据和信息服务。GeneDx 利用集成的实验室流程、软件工具和信息学功能组合来处理含脱氧核糖核酸 (DNA) 的样本，分析有关患者特定遗传变异的信息并为临床医生及其患者生成测试报告。GeneDx 提供各种基因诊断测试、筛查解决方案和信息。Legacy Sema4 诊断部门提供生殖和女性健康以及躯体肿瘤诊断测试和筛查产品。
GeneDx Holdings Corp简介
公司代码WGS
公司名称GeneDx Holdings Corp
上市日期Sep 04, 2020
CEOMs. Katherine A. Stueland
员工数量1000
证券类型Ordinary Share
年结日Sep 04
公司地址333 Ludlow Street
城市STAMFORD
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编06902
电话18887291206
网址https://sema4.com/
公司代码WGS
上市日期Sep 04, 2020
CEOMs. Katherine A. Stueland
GeneDx Holdings Corp公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
3.75K
-8.86%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
3.58K
-82.23%
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
3.75K
-8.86%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
3.58K
-82.23%
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Patients with third party insurance
81.10M
78.98%
Institutional customers
18.38M
17.90%
Other
2.87M
2.79%
Self pay patients
339.00K
0.33%
暂无数据
业务
地区
业务USD
名称
营收
占比
Patients with third party insurance
81.10M
78.98%
Institutional customers
18.38M
17.90%
Other
2.87M
2.79%
Self pay patients
339.00K
0.33%
股东统计
更新时间: 10月31日 周五
更新时间: 10月31日 周五
持股股东
股东类型
持股股东
持股股东
占比
Corvex Management LP
10.58%
Casdin Capital, LLC
10.54%
William Blair Investment Management, LLC
5.64%
Icahn School of Medicine at Mount Sinai
4.75%
OPKO Health Inc
4.74%
其他
63.74%
持股股东
持股股东
占比
Corvex Management LP
10.58%
Casdin Capital, LLC
10.54%
William Blair Investment Management, LLC
5.64%
Icahn School of Medicine at Mount Sinai
4.75%
OPKO Health Inc
4.74%
其他
63.74%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
36.63%
Hedge Fund
36.17%
Investment Advisor
31.04%
Corporation
10.65%
Research Firm
6.54%
Individual Investor
1.61%
Pension Fund
0.81%
Venture Capital
0.54%
Bank and Trust
0.48%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
427
31.75M
110.52%
-296.44K
2025Q2
397
34.23M
119.24%
+1.02M
2025Q1
398
32.79M
115.46%
-47.86K
2024Q4
341
29.17M
104.22%
+1.72M
2024Q3
289
26.18M
97.50%
+377.48K
2024Q2
262
24.98M
95.33%
+588.25K
2024Q1
260
22.13M
86.19%
+1.41M
2023Q4
271
20.57M
80.67%
-567.28K
2023Q3
283
21.68M
85.29%
-751.02K
2023Q2
291
21.85M
86.03%
-864.88K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Corvex Management LP
3.06M
10.65%
--
--
Aug 22, 2025
Casdin Capital, LLC
3.05M
10.6%
-461.51K
-13.16%
Aug 22, 2025
William Blair Investment Management, LLC
1.63M
5.68%
+442.41K
+37.21%
Jun 30, 2025
Icahn School of Medicine at Mount Sinai
1.37M
4.78%
-1.35M
-49.50%
Feb 21, 2025
OPKO Health Inc
1.37M
4.77%
-800.83K
-36.88%
Nov 20, 2024
BlackRock Institutional Trust Company, N.A.
1.28M
4.45%
+241.28K
+23.25%
Jun 30, 2025
Pentwater Capital Management LP
1.22M
4.25%
+1.19M
+3712.50%
Jun 30, 2025
The Vanguard Group, Inc.
1.18M
4.09%
+148.96K
+14.50%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
1.04M
3.61%
+533.38K
+105.89%
Jun 30, 2025
UBS Financial Services, Inc.
1.00M
3.49%
+951.52K
+1895.62%
Jun 30, 2025
查看更多
持股ETF
更新时间: 10月6日 周一
更新时间: 10月6日 周一
机构名称
占比
Global X Genomics & Biotechnology ETF
3.85%
SPDR S&P Health Care Services ETF
3.59%
Innovator IBD 50 Fund ETF
3.05%
Alger Mid Cap 40 ETF
2.05%
Harbor Health Care ETF
2.05%
Simplify Health Care ETF
1.32%
Franklin Genomic Advancements ETF
1.23%
Main Thematic Innovation ETF
1.02%
Hypatia Women CEO ETF
0.87%
ARK Genomic Revolution ETF
0.83%
查看更多
Global X Genomics & Biotechnology ETF
占比3.85%
SPDR S&P Health Care Services ETF
占比3.59%
Innovator IBD 50 Fund ETF
占比3.05%
Alger Mid Cap 40 ETF
占比2.05%
Harbor Health Care ETF
占比2.05%
Simplify Health Care ETF
占比1.32%
Franklin Genomic Advancements ETF
占比1.23%
Main Thematic Innovation ETF
占比1.02%
Hypatia Women CEO ETF
占比0.87%
ARK Genomic Revolution ETF
占比0.83%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
公告日期
类型
比率
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
